scispace - formally typeset
M

Michael Emerman

Researcher at Fred Hutchinson Cancer Research Center

Publications -  174
Citations -  24937

Michael Emerman is an academic researcher from Fred Hutchinson Cancer Research Center. The author has contributed to research in topics: Virus & Gene. The author has an hindex of 71, co-authored 164 publications receiving 22900 citations. Previous affiliations of Michael Emerman include Pasteur Institute & University of California, Irvine.

Papers
More filters
Journal ArticleDOI

A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.

David E. Gordon, +128 more
- 30 Apr 2020 - 
TL;DR: A human–SARS-CoV-2 protein interaction map highlights cellular processes that are hijacked by the virus and that can be targeted by existing drugs, including inhibitors of mRNA translation and predicted regulators of the sigma receptors.
Journal ArticleDOI

Genome organization and transactivation of the human immunodeficiency virus type 2.

TL;DR: Analysis of the nucleotide sequence of the human retrovirus associated with AIDS in West Africa, HIV-2, shows that it is evolutionary distant from the previously characterized HIV-1, and suggests that these viruses existed long before the current AIDS epidemics.
Journal ArticleDOI

Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene.

TL;DR: A HeLa cell line is constructed that both expresses high levels of CD4 and contains a single integrated copy of a beta-galactosidase gene that is under the control of a truncated human immunodeficiency virus type 1 (HIV-1) long terminal repeat (LTR).
Journal ArticleDOI

A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells

TL;DR: HIV-1 mutants containing amino-acid substitutions in this nuclear localization signal integrate and replicate within dividing but not growth-arrested cells, and thus display a phenotype more representative of an onco-retrovirus.